Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Semaphorin 6D tunes amygdalar circuits for emotional, metabolic, and inflammatory outputs.
Nakanishi Y, Izumi M, Matsushita H, Koyama Y, Diez D, Takamatsu H, Koyama S, Nishide M, Naito M, Mizuno Y, Yamaguchi Y, Mae T, Noda Y, Nakaya K, Nojima S, Sugihara F, Okuzaki D, Ikawa M, Shimada S, Kang S, Kumanogoh A. Nakanishi Y, et al. Among authors: mizuno y. Neuron. 2024 Sep 4;112(17):2955-2972.e9. doi: 10.1016/j.neuron.2024.06.017. Epub 2024 Jul 12. Neuron. 2024. PMID: 39002542 Free article.
Semaphorin 6D-expressing mesenchymal cells regulate IL-10 production by ILC2s in the lung.
Naito M, Nakanishi Y, Motomura Y, Takamatsu H, Koyama S, Nishide M, Naito Y, Izumi M, Mizuno Y, Yamaguchi Y, Nojima S, Okuzaki D, Kumanogoh A. Naito M, et al. Among authors: mizuno y. Life Sci Alliance. 2022 Aug 29;5(11):e202201486. doi: 10.26508/lsa.202201486. Print 2022 Nov. Life Sci Alliance. 2022. PMID: 36038260 Free PMC article.
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Hirai T, Naito Y, Koyama S, Nakanishi Y, Masuhiro K, Izumi M, Kuge T, Naito M, Mizuno Y, Yamaguchi Y, Kang S, Yaga M, Futami Y, Nojima S, Nishide M, Morita T, Kato Y, Tsuda T, Takemoto N, Kinugasa-Katayama Y, Aoshi T, Villa JK, Yamashita K, Enokida T, Hoshi Y, Matsuura K, Tahara M, Takamatsu H, Takeda Y, Inohara H, Kumanogoh A. Hirai T, et al. Among authors: mizuno y. JCI Insight. 2024 Feb 8;9(3):e166349. doi: 10.1172/jci.insight.166349. JCI Insight. 2024. PMID: 38329122 Free PMC article.
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
Yamaguchi Y, Maeda Y, Shibahara T, Nameki S, Nakabayashi A, Komuta K, Mizuno Y, Yagita M, Manabe Y, Morita T, Nishide M, Watanabe A, Takamatsu H, Nishida S, Hirano T, Shima Y, Narazaki M, Kumanogoh A. Yamaguchi Y, et al. Among authors: mizuno y. Mod Rheumatol Case Rep. 2020 Jul;4(2):302-309. doi: 10.1080/24725625.2020.1717747. Epub 2020 Feb 3. Mod Rheumatol Case Rep. 2020. PMID: 33087016 Review.
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component.
Shirai Y, Nakanishi Y, Suzuki A, Konaka H, Nishikawa R, Sonehara K, Namba S, Tanaka H, Masuda T, Yaga M, Satoh S, Izumi M, Mizuno Y, Jo T, Maeda Y, Nii T, Oguro-Igashira E; Biobank Japan Project; Morisaki T, Kamatani Y, Nakayamada S, Nishigori C, Tanaka Y, Takeda Y, Yamamoto K, Kumanogoh A, Okada Y. Shirai Y, et al. Among authors: mizuno y. Ann Rheum Dis. 2022 Aug 11;81(9):1301-1312. doi: 10.1136/annrheumdis-2022-222460. Ann Rheum Dis. 2022. PMID: 35753705 Free PMC article.
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study.
Otsuka T, Nishida S, Shibahara T, Temizoz B, Hamaguchi M, Shiroyama T, Kimura K, Miyake K, Hirata H, Mizuno Y, Yagita M, Manabe Y, Kuroda E, Takeda Y, Kida H, Ishii KJ, Kumanogoh A. Otsuka T, et al. Among authors: mizuno y. BMC Cancer. 2022 Jul 7;22(1):744. doi: 10.1186/s12885-022-09818-4. BMC Cancer. 2022. PMID: 35799134 Free PMC article. Clinical Trial.
2,576 results